Moreover, they further demonstrate that C1QBP is capable of promoting viability and tumorigenicity of breast cancer cells by regulating oxidative phosphorylation and opposing the shift of cell metabolism toward glycolysis, highly indicating that C1QBP may serve as a promising target for diagnosis and therapy for breast cancer (Fogal et al., 2010). Here, C1QBP is linked to breast carcinoma.